Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid: bedside-to-bench report

Lung carcinoids are neuroendocrine tumors representing 1 to 2% of lung cancers. This study outlines the case of a patient with a metastatic lung atypical carcinoid who presented with a pleural effusion and progression of liver metastases after developing resistance to conventional treatments. Person...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, Hi Chul (Author) , El-Khoury, Victoria (Author) , Schulte, Nadine (Author) , Zhan, Tianzuo (Author) , Betge, Johannes (Author) , Cousin, Loic (Author) , Felli, Emanuele (Author) , Pessaux, Patrick (Author) , Ogier, Arnaud (Author) , Opitz, Oliver (Author) , Ku, Bosung (Author) , Ebert, Matthias (Author) , Kwon, Yong-Jun (Author)
Format: Article (Journal)
Language:English
Published: 22 Feb 2022
In: Cancer biology & therapy
Year: 2022, Volume: 23, Issue: 1, Pages: 96-102
ISSN:1555-8576
DOI:10.1080/15384047.2021.2021042
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1080/15384047.2021.2021042
Verlag, kostenfrei, Volltext: https://www.tandfonline.com/doi/full/10.1080/15384047.2021.2021042
Get full text
Author Notes:Hichul Kim, Victoria El-Khoury, Nadine Schulte, Tianzuo Zhan, Johannes Betge, Loic Cousin, Emanuele Felli, Patrick Pessaux, Arnaud Ogier, Oliver G Opitz, Bosung Ku, Matthias P Ebert, and Yong-Jun Kwon

MARC

LEADER 00000caa a2200000 c 4500
001 1848869290
003 DE-627
005 20230706222902.0
007 cr uuu---uuuuu
008 230613s2022 xx |||||o 00| ||eng c
024 7 |a 10.1080/15384047.2021.2021042  |2 doi 
035 |a (DE-627)1848869290 
035 |a (DE-599)KXP1848869290 
035 |a (OCoLC)1389533472 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kim, Hi Chul  |e VerfasserIn  |0 (DE-588)1292616571  |0 (DE-627)1848866879  |4 aut 
245 1 0 |a Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid  |b bedside-to-bench report  |c Hichul Kim, Victoria El-Khoury, Nadine Schulte, Tianzuo Zhan, Johannes Betge, Loic Cousin, Emanuele Felli, Patrick Pessaux, Arnaud Ogier, Oliver G Opitz, Bosung Ku, Matthias P Ebert, and Yong-Jun Kwon 
264 1 |c 22 Feb 2022 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.06.2023 
520 |a Lung carcinoids are neuroendocrine tumors representing 1 to 2% of lung cancers. This study outlines the case of a patient with a metastatic lung atypical carcinoid who presented with a pleural effusion and progression of liver metastases after developing resistance to conventional treatments. Personalized functional profiling (PFP), i.e. drug screening, was performed in ex-vivo spheroids obtained from the patient’s liver metastasis to identify potential therapeutic options. The drug screening results revealed cediranib, an antiangiogenic drug, as a hit drug for this patient, from a library of 66 Food and Drug Administration (FDA)-approved and investigational drugs. Based on the PFP results and the reported evidence of clinical efficacy of bevacizumab and capecitabine combination in gastro-intestinal neuroendocrine tumors, this combination was given to the patient. Four months later, the pleural effusion and pleura carcinosis regressed and the liver metastasis did not progress. The patient experienced 2 years of a stable disease under the PFP-guided personalized treatment. 
650 4 |a antiangiogenic therapy 
650 4 |a drug screening 
650 4 |a lung carcinoid 
650 4 |a neuroendocrine tumors 
650 4 |a Personalized functional profiling 
650 4 |a personalized medicine 
650 4 |a pharmacotyping 
650 4 |a precision medicine 
650 4 |a spheroids 
700 1 |a El-Khoury, Victoria  |e VerfasserIn  |4 aut 
700 1 |a Schulte, Nadine  |d 1981-  |e VerfasserIn  |0 (DE-588)138942404  |0 (DE-627)703158511  |0 (DE-576)308939069  |4 aut 
700 1 |a Zhan, Tianzuo  |d 1985-  |e VerfasserIn  |0 (DE-588)1019998911  |0 (DE-627)691070105  |0 (DE-576)359019544  |4 aut 
700 1 |a Betge, Johannes  |d 1986-  |e VerfasserIn  |0 (DE-588)108257421X  |0 (DE-627)847674347  |0 (DE-576)455525021  |4 aut 
700 1 |a Cousin, Loic  |e VerfasserIn  |4 aut 
700 1 |a Felli, Emanuele  |e VerfasserIn  |4 aut 
700 1 |a Pessaux, Patrick  |e VerfasserIn  |4 aut 
700 1 |a Ogier, Arnaud  |e VerfasserIn  |4 aut 
700 1 |a Opitz, Oliver  |d 1968-  |e VerfasserIn  |0 (DE-588)114318689  |0 (DE-627)519851315  |0 (DE-576)289793106  |4 aut 
700 1 |a Ku, Bosung  |e VerfasserIn  |4 aut 
700 1 |a Ebert, Matthias  |d 1968-  |e VerfasserIn  |0 (DE-588)1030133522  |0 (DE-627)734827083  |0 (DE-576)377938432  |4 aut 
700 1 |a Kwon, Yong-Jun  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancer biology & therapy  |d London : Informa UK Limited, Taylor & Francis Group, 2002  |g 23(2022), 1, Seite 96-102  |h Online-Ressource  |w (DE-627)354543873  |w (DE-600)2088895-8  |w (DE-576)321220102  |x 1555-8576  |7 nnas  |a Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid bedside-to-bench report 
773 1 8 |g volume:23  |g year:2022  |g number:1  |g pages:96-102  |g extent:7  |a Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid bedside-to-bench report 
856 4 0 |u https://doi.org/10.1080/15384047.2021.2021042  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.tandfonline.com/doi/full/10.1080/15384047.2021.2021042  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230613 
993 |a Article 
994 |a 2022 
998 |g 1030133522  |a Ebert, Matthias  |m 1030133522:Ebert, Matthias  |d 60000  |d 61100  |e 60000PE1030133522  |e 61100PE1030133522  |k 0/60000/  |k 1/60000/61100/  |p 12 
998 |g 114318689  |a Opitz, Oliver  |m 114318689:Opitz, Oliver  |d 60000  |d 61100  |e 60000PO114318689  |e 61100PO114318689  |k 0/60000/  |k 1/60000/61100/  |p 10 
998 |g 108257421X  |a Betge, Johannes  |m 108257421X:Betge, Johannes  |d 60000  |d 61100  |e 60000PB108257421X  |e 61100PB108257421X  |k 0/60000/  |k 1/60000/61100/  |p 5 
998 |g 1019998911  |a Zhan, Tianzuo  |m 1019998911:Zhan, Tianzuo  |d 60000  |d 61100  |e 60000PZ1019998911  |e 61100PZ1019998911  |k 0/60000/  |k 1/60000/61100/  |p 4 
998 |g 138942404  |a Schulte, Nadine  |m 138942404:Schulte, Nadine  |d 60000  |d 61100  |e 60000PS138942404  |e 61100PS138942404  |k 0/60000/  |k 1/60000/61100/  |p 3 
999 |a KXP-PPN1848869290  |e 4334910696 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 13.06.2023"],"relHost":[{"origin":[{"publisherPlace":"London ; Georgetown, Tex.","dateIssuedKey":"2002","publisher":"Informa UK Limited, Taylor & Francis Group ; Landes Bioscience","dateIssuedDisp":"2002-"}],"id":{"issn":["1555-8576"],"zdb":["2088895-8"],"eki":["354543873"]},"part":{"issue":"1","year":"2022","pages":"96-102","volume":"23","text":"23(2022), 1, Seite 96-102","extent":"7"},"recId":"354543873","disp":"Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid bedside-to-bench reportCancer biology & therapy","title":[{"title":"Cancer biology & therapy","subtitle":"CB&T","title_sort":"Cancer biology & therapy"}],"titleAlt":[{"title":"Cancer biology and therapy"},{"title":"CB&T"}],"note":["Gesehen am 16.02.2022"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2002 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"7 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid","subtitle":"bedside-to-bench report","title":"Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid"}],"person":[{"display":"Kim, Hi Chul","family":"Kim","given":"Hi Chul","role":"aut"},{"display":"El-Khoury, Victoria","family":"El-Khoury","role":"aut","given":"Victoria"},{"family":"Schulte","given":"Nadine","role":"aut","display":"Schulte, Nadine"},{"display":"Zhan, Tianzuo","role":"aut","given":"Tianzuo","family":"Zhan"},{"display":"Betge, Johannes","family":"Betge","given":"Johannes","role":"aut"},{"display":"Cousin, Loic","family":"Cousin","role":"aut","given":"Loic"},{"display":"Felli, Emanuele","given":"Emanuele","role":"aut","family":"Felli"},{"family":"Pessaux","role":"aut","given":"Patrick","display":"Pessaux, Patrick"},{"display":"Ogier, Arnaud","role":"aut","given":"Arnaud","family":"Ogier"},{"family":"Opitz","role":"aut","given":"Oliver","display":"Opitz, Oliver"},{"given":"Bosung","role":"aut","family":"Ku","display":"Ku, Bosung"},{"display":"Ebert, Matthias","role":"aut","given":"Matthias","family":"Ebert"},{"family":"Kwon","given":"Yong-Jun","role":"aut","display":"Kwon, Yong-Jun"}],"recId":"1848869290","name":{"displayForm":["Hichul Kim, Victoria El-Khoury, Nadine Schulte, Tianzuo Zhan, Johannes Betge, Loic Cousin, Emanuele Felli, Patrick Pessaux, Arnaud Ogier, Oliver G Opitz, Bosung Ku, Matthias P Ebert, and Yong-Jun Kwon"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"22 Feb 2022"}],"id":{"eki":["1848869290"],"doi":["10.1080/15384047.2021.2021042"]}} 
SRT |a KIMHICHULEPERSONALIZ2220